Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 11:8:107.
doi: 10.3389/fnsys.2014.00107. eCollection 2014.

Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate

Affiliations

Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate

Hannah Maslen et al. Front Syst Neurosci. .

Abstract

THERE ARE NUMEROUS WAYS PEOPLE CAN IMPROVE THEIR COGNITIVE CAPACITIES: good nutrition and regular exercise can produce long-term improvements across many cognitive domains, whilst commonplace stimulants such as coffee temporarily boost levels of alertness and concentration. Effects like these have been well-documented in the medical literature and they raise few (if any) ethical issues. More recently, however, clinical research has shown that the off-label use of some pharmaceuticals can, under certain conditions, have modest cognition-improving effects. Substances such as methylphenidate and modafinil can improve capacities such as working memory and concentration in some healthy individuals. Unlike their more mundane predecessors, these methods of "cognitive enhancement" are thought to raise a multitude of ethical issues. This paper presents the six principal ethical issues raised in relation to pharmacological cognitive enhancers (PCEs)-issues such as whether: (1) the medical safety-profile of PCEs justifies restricting or permitting their elective or required use; (2) the enhanced mind can be an "authentic" mind; (3) individuals might be coerced into using PCEs; (4), there is a meaningful distinction to be made between the treatment vs. enhancement effect of the same PCE; (5) unequal access to PCEs would have implications for distributive justice; and (6) PCE use constitutes cheating in competitive contexts. In reviewing the six principal issues, the paper discusses how neuroscientific research might help advance the ethical debate. In particular, the paper presents new arguments about the contribution neuroscience could make to debates about justice, fairness, and cheating, ultimately concluding that neuroscientific research into "personalized enhancement" will be essential if policy is to be truly informed and ethical. We propose an "ethical agenda" for neuroscientific research into PCEs.

Keywords: brain function augmentation; cheating; cognitive enhancement; ethics; justice; modafinil; personalized enhancement; ritalin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Academy of Medical Sciences, Royal Society, British Academy, Royal Academy of Engineering. (2012). Human Enhancement and the Future of Work (Report from Joint Workshop). Available online at: http://www.acmedsci.ac.uk/p47prid102.html#downloads (Accessed 22 May 2013).
    1. Advokat C. (2010). What are the cognitive effects of stimulant medication? Emphasis on adults with attentiondeficit/hyperactivity disorder. Neurosci. Biobehav. Rev. 34, 1256–1266 10.1016/j.neubiorev.2010.03.006 - DOI - PubMed
    1. Beglinger L. J., Gaydos B. L., Kareken D. A., Tangphao-Daniels O., Siemers E. R., Mohs R. C. (2004). Neuropsychological test performance in healthy volunteers before and after donepezil administration. J. Psychopharmacol. 18, 102–108 10.1177/0269881104040248 - DOI - PubMed
    1. Beglinger L. J., Tangphao-Daniels O., Kareken D. A., Zhang L., Mohs R., Siemers E. R. (2005). Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study. J. Clin. Psychopharmacol. 25, 159–165 10.1097/01.jcp.0000155822.51962.b4 - DOI - PubMed
    1. Bolt I., Schermer M. (2009). Psychopharmacological enhancers: enhancing identity? Neuroethics 2, 103–111 10.1007/s12152-008-9031-7 - DOI

LinkOut - more resources